Several studies reported the use of alternative controls among patients whose cancers had ISH-equivocal status.19,20,21,22,26 In these studies, if any HER2-to-alternative probe ratio was 2.0 or more, the breast cancer was upgraded to ISH-positive.19,20,21,26. This evidence concerns the gene ERBB2 and breast cancer.